Is CyberArk The Next Big Cybersecurity Stock?
CyberArk Software (NASDAQ: CYBR) recently reported phenomenal quarter numbers, passing…
Sell
38
SEE Quote, Financials, Valuation and Earnings
Last price:
$29.87
Seasonality move
:
4.87%
Day range:
$29.68 - $30.34
52-week range:
$29.33 - $41.14
Dividend yield:
2.65%
P/E ratio:
16.67x
P/S ratio:
0.82x
P/B ratio:
7.04x
Volume:
1.9M
Avg. volume:
1.6M
1-year change:
-16.45%
Market cap:
$4.4B
Revenue:
$5.4B
EPS (TTM):
$1.81
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.9B | $5.5B | $5.6B | $5.5B | $5.4B | |
| Revenue Growth (YoY) | 2.34% | 12.86% | 1.95% | -2.71% | -1.76% | |
| Cost of Revenues | $3.3B | $3.9B | $3.9B | $3.8B | $3.8B | |
| Gross Profit | $1.6B | $1.7B | $1.8B | $1.6B | $1.6B | |
| Gross Profit Margin | 32.82% | 30.38% | 31.42% | 29.9% | 30.14% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $773.7M | $772.4M | $786.2M | $759.1M | $752.6M | |
| Other Inc / (Exp) | $8.8M | $19.3M | -$53.9M | -$121.2M | -$99.1M | |
| Operating Expenses | $811.2M | $811.2M | $822.3M | $821.8M | $815.2M | |
| Operating Income | $798.1M | $869.7M | $950.6M | $819.5M | $809.9M | |
| Net Interest Expenses | $180.7M | $172.8M | $167.4M | $268.6M | $252.4M | |
| EBT. Incl. Unusual Items | $626.2M | $716.2M | $729.3M | $429.7M | $458.4M | |
| Earnings of Discontinued Ops. | $18.8M | $15.6M | $300K | $2.3M | -$4.8M | |
| Income Tax Expense | $142.1M | $225M | $238M | $90.4M | $188.9M | |
| Net Income to Company | $502.9M | $506.8M | $491.6M | $341.6M | $264.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $502.9M | $506.8M | $491.6M | $341.6M | $264.7M | |
| Basic EPS (Cont. Ops) | $3.24 | $3.36 | $3.37 | $2.37 | $1.82 | |
| Diluted EPS (Cont. Ops) | $3.22 | $3.32 | $3.33 | $2.36 | $1.81 | |
| Weighted Average Basic Share | $155.2M | $150.9M | $145.9M | $144.4M | $145.5M | |
| Weighted Average Diluted Share | $156M | $152.4M | $147.4M | $144.9M | $146M | |
| EBITDA | $974.8M | $1.1B | $1.1B | $940.6M | $987.3M | |
| EBIT | $800.6M | $890.9M | $898.8M | $707.2M | $746.4M | |
| Revenue (Reported) | $4.9B | $5.5B | $5.6B | $5.5B | $5.4B | |
| Operating Income (Reported) | $798.1M | $869.7M | $950.6M | $819.5M | $809.9M | |
| Operating Income (Adjusted) | $800.6M | $890.9M | $898.8M | $707.2M | $746.4M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $1.3B | $1.5B | $1.4B | $1.4B | $1.4B | |
| Revenue Growth (YoY) | 3.23% | 14.21% | -8.2% | -2.02% | -0.34% | |
| Cost of Revenues | $916.5M | $1.1B | $981.9M | $972.6M | $966M | |
| Gross Profit | $424.4M | $475.4M | $424M | $404.9M | $406.8M | |
| Gross Profit Margin | 31.65% | 31.04% | 30.16% | 29.39% | 29.63% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $195.8M | $201.2M | $180.6M | $176.5M | $188.8M | |
| Other Inc / (Exp) | $12.4M | $24.3M | -$11M | -$27.8M | -$58M | |
| Operating Expenses | $205.3M | $210.9M | $189.7M | $193.2M | $204.4M | |
| Operating Income | $219.1M | $264.5M | $234.3M | $211.7M | $202.4M | |
| Net Interest Expenses | $46.6M | $41.8M | $44.1M | $68M | $60M | |
| EBT. Incl. Unusual Items | $184.9M | $247M | $179.2M | $115.9M | $84.4M | |
| Earnings of Discontinued Ops. | $4.7M | $11.9M | -$400K | -$900K | -$6.9M | |
| Income Tax Expense | $47.4M | $78M | $84.5M | -$9M | $84.8M | |
| Net Income to Company | $142.2M | $180.9M | $94.3M | $124M | -$7.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $142.2M | $180.9M | $94.3M | $124M | -$7.3M | |
| Basic EPS (Cont. Ops) | $0.92 | $1.22 | $0.65 | $0.86 | -$0.05 | |
| Diluted EPS (Cont. Ops) | $0.91 | $1.20 | $0.65 | $0.86 | -$0.05 | |
| Weighted Average Basic Share | $155.2M | $148.2M | $144.7M | $144.7M | $145.5M | |
| Weighted Average Diluted Share | $156.6M | $150M | $146.2M | $145.2M | $146.6M | |
| EBITDA | $265.3M | $338.6M | $276.2M | $255.5M | $241.9M | |
| EBIT | $220.8M | $288.1M | $229.4M | $196.8M | $183.5M | |
| Revenue (Reported) | $1.3B | $1.5B | $1.4B | $1.4B | $1.4B | |
| Operating Income (Reported) | $219.1M | $264.5M | $234.3M | $211.7M | $202.4M | |
| Operating Income (Adjusted) | $220.8M | $288.1M | $229.4M | $196.8M | $183.5M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $4.9B | $5.5B | $5.6B | $5.5B | $5.4B | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.3B | $3.9B | $3.9B | $3.8B | $3.8B | |
| Gross Profit | $1.6B | $1.7B | $1.8B | $1.6B | $1.6B | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $773.7M | $772.4M | $780.8M | $769.6M | $756.2M | |
| Other Inc / (Exp) | $8.8M | $19.3M | -$59.3M | -$110.7M | -$95.5M | |
| Operating Expenses | $811.2M | $811.2M | $816.9M | $832.3M | $818.8M | |
| Operating Income | $798.1M | $869.7M | $956M | $809M | $806.3M | |
| Net Interest Expenses | $180.7M | $172.8M | $167.4M | $268.6M | $252.4M | |
| EBT. Incl. Unusual Items | $626.2M | $716.2M | $729.3M | $429.7M | $458.4M | |
| Earnings of Discontinued Ops. | $18.8M | $15.6M | $300K | $2.3M | -$4.8M | |
| Income Tax Expense | $142.1M | $225M | $238M | $90.4M | $188.9M | |
| Net Income to Company | $502.9M | $506.8M | $491.6M | $341.6M | $264.7M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $502.9M | $506.8M | $491.6M | $341.6M | $264.7M | |
| Basic EPS (Cont. Ops) | $3.24 | $3.36 | $3.36 | $2.37 | $1.82 | |
| Diluted EPS (Cont. Ops) | $3.23 | $3.33 | $3.34 | $2.36 | $1.81 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $974.8M | $1.1B | $1.1B | $940.6M | $987.3M | |
| EBIT | $800.6M | $888.9M | $900.5M | $707.2M | $746.4M | |
| Revenue (Reported) | $4.9B | $5.5B | $5.6B | $5.5B | $5.4B | |
| Operating Income (Reported) | $798.1M | $869.7M | $956M | $809M | $806.3M | |
| Operating Income (Adjusted) | $800.6M | $888.9M | $900.5M | $707.2M | $746.4M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Revenue | $5.5B | $5.6B | $5.5B | $5.4B | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $3.9B | $3.9B | $3.8B | $3.8B | -- | |
| Gross Profit | $1.7B | $1.8B | $1.6B | $1.6B | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $772.4M | $780.8M | $769.6M | $756.2M | -- | |
| Other Inc / (Exp) | $19.3M | -$59.3M | -$110.7M | -$95.5M | -- | |
| Operating Expenses | $811.2M | $816.9M | $832.3M | $818.8M | -- | |
| Operating Income | $869.7M | $956M | $809M | $806.3M | -- | |
| Net Interest Expenses | $172.8M | $167.4M | $268.6M | $252.4M | -- | |
| EBT. Incl. Unusual Items | $716.2M | $729.3M | $429.7M | $458.4M | -- | |
| Earnings of Discontinued Ops. | $15.6M | $300K | $2.3M | -$4.8M | -- | |
| Income Tax Expense | $225M | $238M | $90.4M | $188.9M | -- | |
| Net Income to Company | $506.8M | $491.6M | $341.6M | $264.7M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $506.8M | $491.6M | $341.6M | $264.7M | -- | |
| Basic EPS (Cont. Ops) | $3.36 | $3.36 | $2.37 | $1.82 | -- | |
| Diluted EPS (Cont. Ops) | $3.33 | $3.34 | $2.36 | $1.81 | -- | |
| Weighted Average Basic Share | $603.6M | $583.5M | $577.8M | $581.9M | -- | |
| Weighted Average Diluted Share | $609.5M | $589.8M | $579.7M | $584.1M | -- | |
| EBITDA | $1.1B | $1.1B | $940.6M | $987.3M | -- | |
| EBIT | $888.9M | $900.5M | $707.2M | $746.4M | -- | |
| Revenue (Reported) | $5.5B | $5.6B | $5.5B | $5.4B | -- | |
| Operating Income (Reported) | $869.7M | $956M | $809M | $806.3M | -- | |
| Operating Income (Adjusted) | $888.9M | $900.5M | $707.2M | $746.4M | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $548.7M | $561M | $456.1M | $346.1M | $371.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $541M | $620.3M | $592.4M | $442.6M | $443.1M | |
| Inventory | $596.7M | $725.7M | $866.3M | $774.3M | $722.2M | |
| Prepaid Expenses | -- | -- | $12.7M | $72.8M | $36.1M | |
| Other Current Assets | $54.1M | $50.1M | $57.5M | $188.4M | $193.8M | |
| Total Current Assets | $1.9B | $2.1B | $2.1B | $2B | $1.9B | |
| Property Plant And Equipment | $1.3B | $1.3B | $1.3B | $1.5B | $1.5B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.2B | $2.2B | $2.2B | $2.9B | $2.9B | |
| Other Intangibles | $171M | $152.6M | $138.4M | $439M | $381.6M | |
| Other Long-Term Assets | $355.8M | $383.5M | $297.4M | $272.1M | $262.3M | |
| Total Assets | $6.1B | $6.2B | $6.2B | $7.2B | $7B | |
| Accounts Payable | $754.2M | $959.9M | $865.6M | $764.6M | $771M | |
| Accrued Expenses | $534.6M | $515M | $530.4M | $508.4M | $555.9M | |
| Current Portion Of Long-Term Debt | $11.8M | $477M | $434M | $29M | $58M | |
| Current Portion Of Capital Lease Obligations | $34.8M | $31.4M | $24M | $35.9M | $36.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.4B | $2B | $2.1B | $1.5B | $1.6B | |
| Long-Term Debt | $3.7B | $3.2B | $3.2B | $4.5B | $4.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.9B | $6B | $5.9B | $6.7B | $6.4B | |
| Common Stock | $23.2M | $23.2M | $23.3M | $15.4M | $15.5M | |
| Other Common Equity Adj | -$69.3M | -$35.9M | -$15M | -$38.5M | -$17M | |
| Common Equity | $172.5M | $248.7M | $344.1M | $549.5M | $624.5M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $172.5M | $248.7M | $344.1M | $549.5M | $624.5M | |
| Total Liabilities and Equity | $6.1B | $6.2B | $6.2B | $7.2B | $7B | |
| Cash and Short Terms | $548.7M | $561M | $456.1M | $346.1M | $371.8M | |
| Total Debt | $3.7B | $3.7B | $3.7B | $4.7B | $4.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $548.7M | $561M | $456.1M | $346.1M | $371.8M | |
| Short Term Investments | -- | -- | -- | -- | -- | |
| Accounts Receivable, Net | $541M | $620.3M | $592.4M | $442.6M | $443.1M | |
| Inventory | $596.7M | $725.7M | $866.3M | $774.3M | $722.2M | |
| Prepaid Expenses | -- | -- | $12.7M | $72.8M | $36.1M | |
| Other Current Assets | $54.1M | $50.1M | $57.5M | $188.4M | $193.8M | |
| Total Current Assets | $1.9B | $2.1B | $2.1B | $2B | $1.9B | |
| Property Plant And Equipment | $1.3B | $1.3B | $1.3B | $1.5B | $1.5B | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $2.2B | $2.2B | $2.2B | $2.9B | $2.9B | |
| Other Intangibles | $171M | $152.6M | $138.4M | $439M | $381.6M | |
| Other Long-Term Assets | $355.8M | $383.5M | $297.4M | $272.1M | $262.3M | |
| Total Assets | $6.1B | $6.2B | $6.2B | $7.2B | $7B | |
| Accounts Payable | $754.2M | $959.9M | $865.6M | $764.6M | $771M | |
| Accrued Expenses | $534.6M | $515M | $530.4M | $508.4M | $555.9M | |
| Current Portion Of Long-Term Debt | $11.8M | $477M | $434M | $29M | $58M | |
| Current Portion Of Capital Lease Obligations | $34.8M | $31.4M | $24M | $35.9M | $36.3M | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $1.4B | $2B | $2.1B | $1.5B | $1.6B | |
| Long-Term Debt | $3.7B | $3.2B | $3.2B | $4.5B | $4.2B | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $5.9B | $6B | $5.9B | $6.7B | $6.4B | |
| Common Stock | $23.2M | $23.2M | $23.3M | $15.4M | $15.5M | |
| Other Common Equity Adj | -$69.3M | -$35.9M | -$15M | -$38.5M | -$17M | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $172.5M | $248.7M | $344.1M | $549.5M | $624.5M | |
| Total Liabilities and Equity | $6.1B | $6.2B | $6.2B | $7.2B | $7B | |
| Cash and Short Terms | $548.7M | $561M | $456.1M | $346.1M | $371.8M | |
| Total Debt | $3.7B | $3.7B | $3.7B | $4.7B | $4.4B | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $502.9M | $506.8M | $491.6M | $341.6M | $264.7M | |
| Depreciation & Amoritzation | $174.2M | $186.4M | $184.6M | $233.4M | $240.9M | |
| Stock-Based Compensation | $41.7M | $43.5M | $50.5M | $33M | $31.6M | |
| Change in Accounts Receivable | $27.4M | -$110.9M | $2.6M | $73.4M | -$34.1M | |
| Change in Inventories | -$25.2M | -$165.7M | -$178.5M | $136M | -$4.3M | |
| Cash From Operations | $737M | $709.7M | $613.3M | $516.2M | $728M | |
| Capital Expenditures | $181.1M | $213.1M | $237.3M | $244.2M | $220.2M | |
| Cash Acquisitions | $5.4M | $89.3M | -$200K | -$1.2B | $5.2M | |
| Cash From Investing | -$159.8M | -$125.7M | -$243M | -$1.4B | -$232.5M | |
| Dividends Paid (Ex Special Dividend) | -$100.4M | -$115.6M | -$118.5M | -$117.9M | -$118M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $601.5M | $423.3M | $1.8B | $416.2M | |
| Long-Term Debt Repaid | -$116.2M | -$620.9M | -$435M | -$967.4M | -$718.7M | |
| Repurchase of Common Stock | -$33M | -$403.1M | -$280.2M | -$79.9M | -- | |
| Other Financing Activities | -$12.1M | -$31.8M | -$41.8M | -$44.1M | -$17.5M | |
| Cash From Financing | -$261.7M | -$575.8M | -$446.7M | $755.7M | -$432.8M | |
| Beginning Cash (CF) | $262.4M | $548.7M | $561M | $456.1M | $346.1M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $315.5M | $8.2M | -$76.4M | -$106.3M | $62.7M | |
| Ending Cash (CF) | $548.7M | $561M | $456.1M | $346.1M | $371.8M | |
| Levered Free Cash Flow | $555.9M | $496.6M | $376M | $272M | $507.8M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $142.2M | $180.9M | $94.3M | $124M | -$7.3M | |
| Depreciation & Amoritzation | $44.5M | $50.5M | $46.8M | $58.7M | $58.4M | |
| Stock-Based Compensation | $10.5M | $10.4M | $10.6M | $1.6M | $8.2M | |
| Change in Accounts Receivable | $62.6M | $6.3M | $68.3M | $55.3M | $8.7M | |
| Change in Inventories | $51.4M | $3.1M | $110.5M | $75.8M | $51.9M | |
| Cash From Operations | $326.8M | $332.2M | $292.5M | $323.7M | $244.2M | |
| Capital Expenditures | $62.8M | $58.3M | $53.8M | $59.2M | $59.1M | |
| Cash Acquisitions | -$3.4M | $88.3M | $300K | $10.5M | $300K | |
| Cash From Investing | -$58.7M | $28.6M | -$59.2M | -$52.2M | -$67.3M | |
| Dividends Paid (Ex Special Dividend) | -$24.8M | -$29.6M | -$29M | -$29M | -$29.2M | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | -- | -- | -$1.4M | $215.4M | $2.8M | |
| Long-Term Debt Repaid | -$6.2M | -$90.5M | -$2.3M | -$527.8M | -$128.9M | |
| Repurchase of Common Stock | -$13M | -$73.6M | -- | -- | -- | |
| Other Financing Activities | -$600K | -$3.7M | -$500K | -$8.7M | -$1M | |
| Cash From Financing | -$44.6M | -$196.6M | -$27.7M | -$218.5M | -$151.1M | |
| Beginning Cash (CF) | $316.8M | $394.2M | $248.8M | $281.3M | $386M | |
| Foreign Exchange Rate Adjustment | $8.4M | $2.6M | $1.7M | $11.8M | -$40M | |
| Additions / Reductions | $223.5M | $164.2M | $205.6M | $53M | $25.8M | |
| Ending Cash (CF) | $548.7M | $561M | $456.1M | $346.1M | $371.8M | |
| Levered Free Cash Flow | $264M | $273.9M | $238.7M | $264.5M | $185.1M | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $502.9M | $506.8M | $491.6M | $341.6M | $264.7M | |
| Depreciation & Amoritzation | $174.2M | $186.4M | $184.6M | $233.4M | $240.9M | |
| Stock-Based Compensation | $41.7M | $43.5M | $50.5M | $33M | $31.6M | |
| Change in Accounts Receivable | $27.4M | -$110.9M | $2.6M | $73.4M | -$34.1M | |
| Change in Inventories | -$25.2M | -$165.7M | -$178.5M | $136M | -$4.3M | |
| Cash From Operations | $737M | $709.7M | $613.3M | $516.2M | $728M | |
| Capital Expenditures | $181.1M | $213.1M | $237.3M | $244.2M | $220.2M | |
| Cash Acquisitions | $5.4M | $89.3M | -$200K | -$1.2B | $5.2M | |
| Cash From Investing | -$159.8M | -$125.7M | -$243M | -$1.4B | -$232.5M | |
| Dividends Paid (Ex Special Dividend) | -$100.4M | -$115.6M | -$118.5M | -$117.9M | -$118M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | $601.5M | $423.3M | $1.8B | $416.2M | |
| Long-Term Debt Repaid | -$116.2M | -$620.9M | -$435M | -$967.4M | -$718.7M | |
| Repurchase of Common Stock | -$33M | -$403.1M | -$280.2M | -$79.9M | -- | |
| Other Financing Activities | -$12.1M | -$31.8M | -$41.8M | -$44.1M | -$17.5M | |
| Cash From Financing | -$261.7M | -$575.8M | -$446.7M | $755.7M | -$432.8M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | $315.5M | $8.2M | -$76.4M | -$106.3M | $62.7M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $555.9M | $496.6M | $376M | $272M | $507.8M | |
| Period Ending | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $506.8M | $491.6M | $341.6M | $264.7M | -- | |
| Depreciation & Amoritzation | $186.4M | $184.6M | $233.4M | $240.9M | -- | |
| Stock-Based Compensation | $43.5M | $50.5M | $33M | $31.6M | -- | |
| Change in Accounts Receivable | -$110.9M | $2.6M | $73.4M | -$34.1M | -- | |
| Change in Inventories | -$165.7M | -$178.5M | $136M | -$4.3M | -- | |
| Cash From Operations | $709.7M | $613.3M | $516.2M | $728M | -- | |
| Capital Expenditures | $213.1M | $237.3M | $244.2M | $220.2M | -- | |
| Cash Acquisitions | $89.3M | -$200K | -$1.2B | $5.2M | -- | |
| Cash From Investing | -$125.7M | -$243M | -$1.4B | -$232.5M | -- | |
| Dividends Paid (Ex Special Dividend) | -$115.6M | -$118.5M | -$117.9M | -$118M | -- | |
| Special Dividend Paid | -- | -- | -- | -- | -- | |
| Long-Term Debt Issued | $601.5M | $423.3M | $1.8B | $416.2M | -- | |
| Long-Term Debt Repaid | -$620.9M | -$435M | -$967.4M | -$718.7M | -- | |
| Repurchase of Common Stock | -$403.1M | -$280.2M | -$79.9M | -- | -- | |
| Other Financing Activities | -$31.8M | -$41.8M | -$44.1M | -$17.5M | -- | |
| Cash From Financing | -$575.8M | -$446.7M | $755.7M | -$432.8M | -- | |
| Beginning Cash (CF) | $1.6B | $1.4B | $1.3B | $1.5B | -- | |
| Foreign Exchange Rate Adjustment | $4.1M | -$28.5M | -$3.7M | -$37M | -- | |
| Additions / Reductions | $8.2M | -$76.4M | -$106.3M | $62.7M | -- | |
| Ending Cash (CF) | $1.6B | $1.3B | $1.2B | $1.5B | -- | |
| Levered Free Cash Flow | $496.6M | $376M | $272M | $507.8M | -- | |
Get SEE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SEE
Sector
P/E ratio
16.67x
16.18x
PEG ratio
0.47x
0.00x
P/B ratio
7.04x
1.28x
Price / LTM sales
0.82x
1.43x
Growth Metrics
SEE
Sector
Revenue growth
-0.34%
1.15%
Earnings growth
61.54%
-0.1%
Revenue (5-year growth)
2.39%
3.88%
Earnings forecast
$0.67
$0.03
Profitability
SEE
Sector
Profitability FY 2024
$1.6B
$54.2K
Return on invested capital
5.09%
2.08%
Return on assets
3.68%
1.28%
Return on equity
41.44%
2.89%
Earnings Date
Last Earnings Date
Feb
25
Next Earnings Date
May
2
Estimated Next Earnings Date
May
27
Balance Sheet
SEE
Sector
Total cash
$371.8M
$2.6M
Short term investments
--
$448.5K
Total assets
$7B
$24.6M
Long term debt
$4.4B
$88.6M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
52
RGC alert for Mar 18
Regencell Bioscience Holdings [RGC] is up 73.51% over the past day.
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 3.96% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is up 0.93% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
